Dr. Angelos M. Stergiou: The SELLAS Life Sciences Group Team

Dr. Angelos M. Stergiou, MD is the Founder, Chief Executive Officer (CEO) and Vice Chairman of the SELLAS Life Sciences Group. Dr. Angelos Stergiou founded SELLAS Life Sciences with his friend and colleague, Dr. Miltos K. Sugiultzoglu, MD and, through their company, they partnered with Memorial Sloan Kettering Cancer Center and began furthering the development of the WT1 cancer vaccine.

Also within the company is the SVP, Chief Medical Officer, Nicholas Sarlos, MD, PhD, FACP; the Chief Regulatory Officer, Gregory M. Torre, PhD, JD; the Chief Operating Officer, Martin G. Baum; the Chief Financial Officer, William Pollett; the SVP and Head of Clinical Development, Anthony Williams, MBBS, Senior VP; the VP of Clinical Operations and Biostatistics, Laura M. Katz, MPH and the VP of Legal Affairs, David Moser.

To know more about the SELLAS Life Sciences Group, please checkout this link:  http://www.prnewswire.com/news-releases/sellas-life-sciences-announces-positive-interim-phase-ii-results-from-its-wt1-immunotherapeutic-anti-cancer-treatment-in-multiple-myeloma-patients-300343924.html


About Angelos Stergiou

Dr. Angelos M. Stergiou, MD, ScD h.c. is shaping the world through biotechnology, and you could too.
This entry was posted in Angelos Stergiou and tagged , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s